Category:Statins

**estatina**
	class of drugs used to lower cholesterol levels
	Carregar ficheiro
	Wikipédia
Instância de	drug class; group or class of chemical entities;
Subclasse de	medicamento; anticholesteremic agents; inibição enzimática; oxidoreductase inhibitor;
Parte de	response to statin (reactant);
Arquivo de autoridade
	Q954845; número de controlo da Biblioteca do Congresso: sh00001691; identificador AUT NKC: ph602573; identificador em BabelNet: 00051454n; identificador J9U da Biblioteca Nacional de Israel: 987007285397905171
	Reasonator; Scholia; Wikidocumentaries; PetScan; estatística; WikiMap; Locator tool; ficheiro KML; Pesquisa retratada;

Subcategorias

Esta categoria só contém a seguinte subcategoria.

H

HMG-CoA reductase inhibitors‎ (9 C, 24 F)

Multimédia na categoria "Statins"

Esta categoria contém os seguintes 41 ficheiros (de um total de 41).

Advlip.jpg 911 × 615; 51 kB
Algorithm for statin-associated myopathy.jpg 810 × 900; 88 kB
Biosynthesis-dielsalder.png 1 523 × 1 602; 77 kB
Biosynthesis-lovd.png 1 442 × 1 177; 60 kB
Cholesterolbiosynthesis.png 1 930 × 2 427; 40 kB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s2.ogv 20 s, 1 344 × 1 024; 15,49 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s3.ogv 20 s, 1 344 × 1 024; 12,31 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s4.ogv 20 s, 1 344 × 1 024; 10,26 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s5.ogv 19 s, 1 344 × 1 024; 18,75 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s6.ogv 13 s, 1 344 × 1 024; 10,5 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s7.ogv 13 s, 1 344 × 1 024; 9 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s8.ogv 13 s, 1 344 × 1 024; 10,57 MB
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s9.ogv 13 s, 1 344 × 1 024; 8,86 MB
Estatina final.png 315 × 209; 13 kB
Estatina.png 578 × 174; 17 kB
Fluvastatina Grupo fluorofenil.jpg 468 × 311; 26 kB
HMG-CoA reductase pathway.svg 500 × 911; 16 kB
Metabolic pathway of a typical statin.png 4 762 × 4 757; 221 kB
Metabolizm i eliminacja statyn oraz potencjalne mechanizmy ich interakcji lekowych 2013.png 3 345 × 1 965; 534 kB
Ogólny mechanizm plejotropowego działania statyn.png 3 507 × 2 480; 403 kB
Schematyczna budowa cząsteczki statyn.png 4 877 × 2 170; 109 kB
Statin final.svg 210 × 139; 14 kB
Statin mechanism v01.svg 652 × 282; 65 kB
Statin pharmacophore 2.png 3 787 × 2 861; 63 kB
Statin pharmacophore.png 665 × 614; 7 kB
Statin pharmacophore.svg 162 × 142; 10 kB
Statin Risks (6941350219).jpg 2 784 × 2 702; 1,08 MB
Statin-Test.png 838 × 759; 66 kB
Statin-use-cardiovascular-disease-death-rate.png 3 400 × 3 844; 1,4 MB
Statin.svg 385 × 116; 17 kB
Statinfamily.png 1 144 × 315; 48 kB
StatinPathway WP430.png 828 × 743; 62 kB
Statins-1.generation v01.svg 988 × 476; 103 kB
Statins77.png 516 × 461; 38 kB
Vectorial pathway for statin distribution from enterocytes to hepatocytes for their pharmacological action and metabolism and elimination via the bile and kidneys.png 3 654 × 2 375; 697 kB
Wpływ fluwastatyny na wskaźniki lipidowe 01.png 1 747 × 1 900; 69 kB
Wpływ fluwastatyny na wskaźniki lipidowe 02.png 1 747 × 1 891; 46 kB
Wpływ fluwastatyny na wskaźniki lipidowe 03.png 1 751 × 1 900; 78 kB
Wpływ prawastatyny na wskaźniki lipidowe 01.png 1 747 × 1 900; 75 kB
Wpływ prawastatyny na wskaźniki lipidowe 02.png 1 747 × 1 891; 77 kB
Wpływ prawastatyny na wskaźniki lipidowe 03.png 1 755 × 1 900; 82 kB

Category:Statins

Subcategorias

H

Multimédia na categoria "Statins"

Menu de navegação

Pesquisa